Development Of An Endometrial Cancer Educational Tool
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- M.D. Anderson Cancer Center
- Enrollment
- 250
- Locations
- 1
- Primary Endpoint
- Safety and Adverse Events (AEs)
Study Overview
Brief Summary
The goal of this study is to develop an online educational tool that we can make widely available to broader patient community.
Detailed Description
Primary Objectives:
-
To develop an EC educational tool for systemic therapy of endometrial cancer.
-
To explore:
-
Acceptability of incorporating the EC educational tool into routine clinical care through a pilot study with EC patients
-
Feasibility, acceptability and the appropriateness of incorporating the EC educational tool into routine clinical care through a pilot study with health care providers of EC patients
-
To estimate the effectiveness of the EC educational tool with EC patients through a pilot study of EC patients and their health care providers.
Study Design
- Study Type
- Interventional
- Allocation
- Non Randomized
- Intervention Model
- Single Group
- Primary Purpose
- Other
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Study Objective 1 (Part A-C see Figure 2)
- •Women who have been diagnosed with endometrial cancer
- •Must be at least 18 years old
- •Must read and speak English or Spanish
- •Must provide written informed consent
- •Study Objectives 2 and 3 (Pilot Study)
- •Women who have been diagnosed with endometrial cancer who are or will be receiving systemic treatment
- •Must be at least 18 years old
- •Must read and speak English or Spanish
- •Must provide written informed consent.
- •Physicians:
- •Study Objective 1 (Qualitative Interviews)
- •Gynecologic oncologists or medical oncologists who practice at MDA or outside institutions
- •Must be able to speak and read English
- •Must provide written informed consent
- •Healthcare Providers:
- •Study Objectives 2 and 3 (Pilot Study)
- •Healthcare Providers (including but not limited to gynecologic oncologists and APPs) who practice at MDA, the HALs or LBJ Hospital who provide care to women diagnosed with endometrial cancer
- •Must be able to speak and read English
- •Must provide written informed consent
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Safety and Adverse Events (AEs)
Time Frame: Through study completion; an average of 1 year
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0
Secondary Outcomes
No secondary outcomes reported